Summary:
- The FDA has approved a new blood test called Elecsys that can help diagnose Alzheimer's disease. This test measures levels of a protein called phospho-tau217, which is a biomarker for Alzheimer's.
- The test can detect Alzheimer's disease up to 20 years before symptoms appear, allowing for earlier diagnosis and treatment. This is important because Alzheimer's is a progressive brain disease that gets worse over time.
- The Elecsys blood test is a significant advancement in Alzheimer's research and diagnosis. It provides a simple, non-invasive way to identify the disease early, which can help patients and their families prepare and seek appropriate care.